Cargando…
S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells
BACKGROUND: The reportedly broad expression of CD85j across different immune cell types suggests an importance for this molecule in the human immune system. Previous reports have shown that this receptor interacts with several HLA class-I molecules, as well as with some viral proteins. We have demon...
Autores principales: | Arnold, Vincent, Cummings, Jean-Saville, Moreno-Nieves, Uriel Y, Didier, Céline, Gilbert, Adrien, Barré-Sinoussi, Françoise, Scott-Algara, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826667/ https://www.ncbi.nlm.nih.gov/pubmed/24156302 http://dx.doi.org/10.1186/1742-4690-10-122 |
Ejemplares similares
-
S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVA(HIV)-Primed NK Cells to Control HIV Infection
por: Moreno-Nieves, Uriel Y., et al.
Publicado: (2015) -
S100A9 protein is a novel ligand for the receptor CD85j and their interaction is implicated in the NK cell-mediated control of HIV-1 replication
por: Moreno Nieves, UY, et al.
Publicado: (2012) -
The CD85j(+) NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
por: Scott-Algara, Daniel, et al.
Publicado: (2008) -
Dynamic Shift from CD85j/ILT-2 to NKG2D NK Receptor Expression Pattern on Human Decidual NK during the First Trimester of Pregnancy
por: Marlin, Romain, et al.
Publicado: (2012) -
OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
por: Cummings, J, et al.
Publicado: (2009)